DermWire TV

Episodes 1-16 of 125

DermwireTV 2024 Year in Review
DermwireTV 2024 Year in Review
DermWire TV
DermwireTV 2024 Year in Review
Vtama Approved for AD in Adults and Children
Vtama Approved for AD in Adults and Children
DermWire TV
Vtama Approved for AD in Adults and Children
Dermwire TV Extra: The Global Access to Skin Health Observatory
Dermwire TV Extra: The Global Access to Skin Health Observatory
DermWire TV
Dermwire TV Extra: The Global Access to Skin Health Observatory
- Esther Freeman, MD, PhD
Experts React to Latest Benzene Analysis
Experts React to Latest Benzene Analysis
DermWire TV
Experts React to Latest Benzene Analysis
FDA Approves Bimzelx for Hidradenitis Suppurativa
FDA Approves Bimzelx for Hidradenitis Suppurativa
DermWire TV
FDA Approves Bimzelx for Hidradenitis Suppurativa
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
Skin of Color
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
- Emily Ruiz, MD, MPH
FDA Approves Rosacea Treatment Emrosi
FDA Approves Rosacea Treatment Emrosi
DermWire TV
FDA Approves Rosacea Treatment Emrosi
DermWire TV Extra: Dr. Swanson on BPO
DermWire TV Extra: Dr. Swanson on BPO
DermWire TV
DermWire TV Extra: Dr. Swanson on BPO
- Lisa Swanson, MD, FAAD
DermWire TV Extra: Dr. Bunick on BPO Study
DermWire TV Extra: Dr. Bunick on BPO Study
DermWire TV
DermWire TV Extra: Dr. Bunick on BPO Study
- Christopher Bunick, MD, PhD, FAAD
FDA Approves Botox for Vertical Platysma Bands
FDA Approves Botox for Vertical Platysma Bands
DermWire TV
FDA Approves Botox for Vertical Platysma Bands
New Analysis of Benzene Contamination in BPO Products
New Analysis of Benzene Contamination in BPO Products
DermWire TV
New Analysis of Benzene Contamination in BPO Products
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
DermWire TV
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
- Melinda Gooderham, MSc, MD, FRCPC
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
DermWire TV
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
NIH Analysis Examines Association Between AD and Comorbidities
NIH Analysis Examines Association Between AD and Comorbidities
DermWire TV
NIH Analysis Examines Association Between AD and Comorbidities
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
DermWire TV
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
- Amber Blair, PA-C
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
DermWire TV
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs

Prev
1
2
3
…
7
8
Next

1/6